Seryx Licenses its Innovative Pharmacogenetics Technology, Signature Genetics(TM), for the Asia/Pacific Rim Markets

06-Feb-2004

Seryx Inc. announced that it has licensed its innovative pharmacogenetics technology, Signature Genetics(TM), for the Asia/Pacific Rim markets. Under the agreement, Seryx Asia, a Singaporean company in which both Seryx and IPREX Asia Pacific are shareholders, will be granted the exclusive rights to commercialize Signature Genetics(TM) in Thailand, Singapore, Hong Kong, Malaysia, Australia and New Zealand.

Signature Genetics(TM) is a turnkey service that offers easy-to-use applications of pharmacogenetics. Through a genetic analysis and a medical history questionnaire, the Signature Genetics(TM) Report provides physicians and patients with personalized information on the patient's ability to metabolize medications, in order to maximize treatment success and minimize adverse drug reactions.

"We are very pleased to enter into this licensing agreement with IPREX Asia Pacific. We are committed to building the Signature Genetics(TM) franchise internationally and are excited by the prospect of providing access to personalized medicine for millions of patients and their physicians", said Patrick Rambaud the CEO and founder of Seryx Inc.

Kien Haw Wong, MD of IPREX Asia Pacific, "we are delighted to be working with Seryx Inc. in this Asian venture and are excited by the potential of Signature Genetics(TM) in this dynamic region where healthcare plays such a crucial role."

Many factors influence the way people respond to medications such as lifestyle, diet and environment. However, it is now recognized by the scientific community that DNA, which contains an individual's genes, plays a major role. Pharmacogenetics is the science of how your genetic make-up can contribute to the way you respond to medicines, including pain-killers with codeine, antidepressants, and many blood pressure and asthma medicines.

Seryx Inc. is a privately held bioinformatics company specializing in Pharmacogenetics with operations in North-America, Europe and the Asia Pacific Rim. Seryx is a pioneer in developing integrated information technology in Pharmacogenetics. Seryx provides physicians with customized information for drug prescriptions and lifestyle changes aimed at improving the health and wellbeing of patients.

https://www.bionity.com/en/news/34960/seryx-licenses-its-innovative-pharmacogenetics-technology-signature-genetics-tm-for-the-asia-pacific-rim-markets.html